DaVita

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
  1. New Morningstar Analyst Report for DaVita HealthCare Partners Inc

    Stock Reports

    Mon, 25 Aug 2014

    DaVita 's profitability is largely dependent on ..... paying exchange plans could adversely affect DaVita 's bottom line.Federal government changes ..... Amgen's Epogen could eventually improve DaVita 's profitability. Management has historically

  2. A Shift in Health-Care M&A Activity

    Headlines

    Sat, 23 Aug 2014

    Speaking of diabetes, how do you view DaVita HealthCare Partners DVA as a potential ..... a certain amount of attractiveness for DaVita in that diabetes is a big contributor to dialysis and DaVita is one of the largest dialysis providers

  3. Update: NxStage Medical Earnings

    Headlines

    Wed, 13 Aug 2014

    compared to its previous guidance of $283 to $288 million. Although established players like Fresenius (NYSE: FMS ) and DaVita (NYSE: DVA ) account for more than half of the conventional dialysis market segment in the US, NxStage Medical's System

  4. Update: DaVita Is Still Undervalued, Despite Headwinds

    Headlines

    Mon, 4 Aug 2014

    By Early Retiree : On July 31 DaVita (NYSE: DVA ) delivered a mixed bag of ..... management. These issues prompted Kent Thiry, DaVita 's CEO, to step in personally to run ..... legacy business will continue to do well. DaVita now expects 2014 consolidated operating

  5. Kidney Care Remains DaVita ’s Bright Spot in a Tough Environment

    Commentary

    Fri, 1 Aug 2014

    Despite weakness in both of DaVita HealthCare Partners’ business segments, the ..... reduction in administrative costs, DaVita upheld healthy segment operating margin ..... treatment growth to remain strong for DaVita . We also expect profitability to improve

  6. Fresenius Meets Expectations and Cautiously Enters Coordinated-Care Market

    Commentary

    Thu, 31 Jul 2014

    Illinois and Texas. We're usually skeptical of deals outside of management's expertise in dialysis, a criticism we share with DaVita 's large merger with Healthcare Partners. While we think Fresenius' global dominance in the dialysis market is enough to

  7. Addition of Verizon and Trimming of GM Most Notable Changes in Berkshire's 1Q Portfolio

    Commentary

    Thu, 15 May 2014

    in March 2009. The only other notable additions during the period was the purchase of an additional 1.2 million shares of DaVita (for $75 million), 233,000 shares of IBM (for $45 million), 724,000 shares of VeriSign (for $40 million), and

  8. Seeking PORT advice...please review current and offer suggestions

    Commentary

    Tue, 6 May 2014

    represents 100% of my employer 401k I have currently have 7k in Roth IRA in FMILX Fedility New Millenium I have approx 50k in DVA Davita healthcare and 12k in CRAY...both showing currently 10k combined in profits from my cost basis. I have 15k in cash in the

  9. Kidney Care Continues to Offset DaVita ’s Struggling Healthcare Partners Business

    Commentary

    Fri, 2 May 2014

    DaVita reported another surprisingly weak quarter ..... value estimate or narrow moat rating for DaVita . Management’s year-end outlook remains ..... reimbursement headwinds will continue to dog both of DaVita ’s segments, but management admitted

  10. Fresenius and DaVita Face Better-Than-Expected 2014, but Reimbursement Pressure Will Persist

    Commentary

    Mon, 25 Nov 2013

    assumptions for both Fresenius Medical Care and DaVita HealthCare Partners after the U.S. Centers ..... expansion. Based on the final rule, DaVita issued an outlook for roughly flat operating ..... division thanks to Medicare Advantage cuts. DaVita ’s management will discuss its outlook

« Prev12345Next »
Content Partners